PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Preclinical Research of Natural Products, Post-Graduate Program in Medicinal Plants and Phytotherapeutics in Basic Attention, Paranaense University, Umuarama, PR, Brazil.\', \'Laboratory of Preclinical Research of Natural Products, Post- Graduate Program in Animal Science with Emphasis on Bioactive Products, Paranaense University, Umuarama, PR, Brazil.\', \'Laboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2174/1381612826666200707121636
?:hasPublicationType
?:journal
  • Current pharmaceutical design
is ?:pmid of
?:pmid
?:pmid
  • 32634080
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.883
?:rankingScore_hIndex
  • 136
?:title
  • Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19).
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32634080>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32634080>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all